The Cigna Group (NYSE:CI) is included among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts.
Photo by
NeONBRAND on
Unsplash
The Cigna Group (NYSE:CI) is an American multinational company offering managed healthcare and insurance services.
On October 27, JPMorgan maintained an Overweight rating on The Cigna Group (NYSE:CI) following an announcement from its Evernorth unit about a new model for Express Scripts commercial customers starting in 2027. This model eliminates rebates and introduces a point-of-sale approach, where customers pay a net price at the time of dispensing.
According to the analyst, the change addresses several regulatory proposals from recent years and should “de-risk” Express Scripts’ commercial operations. JPMorgan added that Cigna’s shift to a de-linked and rebate-free default offering is a “clear signal that it views this as a viable approach for the broader business.”
The Cigna Group (NYSE:CI) also remains attractive to income-focused investors, having increased its dividend for five consecutive years. The stock has a dividend yield of 2.02%, as of October 29.
While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Best Dividend Stocks Under $10 to Invest in and 11 Best FTSE Dividend Stocks to Buy Right Now
Disclosure: None.